MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Apollo Endosurgery Accounts Receivables 2011-2026 | APEN
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 M | 10.1 M | 8.22 M | 9.23 M | 11.4 M | 11.7 M | 10.5 M | 6.99 K | 727 K | 1.31 M | 234 K | 1.33 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15 M | 6.99 K | 6.65 M |
Quarterly Accounts Receivables Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 12.9 M | - | 11.1 M | 10.1 M | 10.3 M | 11.2 M | 9.46 M | 8.22 M | 8.22 M | 8.22 M | 8.22 M | 9.23 M | 9.23 M | 9.23 M | 9.23 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 6.99 K | 6.99 K | 6.99 K | 727 K | 727 K | 727 K | 727 K | 1.31 M | 1.31 M | 1.31 M | 1.31 M | 234 K | 234 K | 234 K | 234 K | 1.33 M | 1.33 M | 1.33 M | 1.33 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 12.9 M | 6.99 K | 6.4 M |
Accounts Receivables of other stocks in the Medical devices industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Conformis
CFMS
|
9.77 M | - | - | $ 16.4 M |  USA |
 |
Acutus Medical
AFIB
|
11.4 M | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
371 M | $ 11.94 | -1.08 % | $ 1.61 B | USA |
 |
Cardiovascular Systems
CSII
|
39.7 M | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
2.37 M | - | 3.58 % | $ 2.21 M | USA |
 |
ClearPoint Neuro
CLPT
|
6.55 M | $ 9.07 | -3.3 % | $ 257 M | USA |
 |
Dynatronics Corporation
DYNT
|
2.8 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
24.7 M | $ 23.78 | 0.72 % | $ 201 M | USA |
 |
Bruker Corporation
BRKR
|
566 M | $ 36.67 | -0.19 % | $ 5.46 K | USA |
 |
Second Sight Medical Products
EYES
|
455 K | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
595 K | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
679 M | $ 90.0 | 1.58 % | $ 12.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
117 K | $ 1.83 | -3.68 % | $ 1.11 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
272 M | $ 9.33 | 0.21 % | $ 719 M | USA |
 |
EDAP TMS S.A.
EDAP
|
17.9 M | $ 3.4 | -1.73 % | $ 127 M |  France |
 |
Avinger
AVGR
|
1.01 M | - | -20.74 % | $ 369 K | USA |
 |
IRIDEX Corporation
IRIX
|
7.61 M | $ 1.03 | 3.35 % | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
346 M | $ 85.11 | -0.61 % | $ 2.96 B | USA |
 |
Align Technology
ALGN
|
996 M | $ 166.87 | -2.91 % | $ 12.5 B | USA |
 |
Invacare Corporation
IVC
|
88 M | - | - | $ 24.7 M | USA |
 |
AxoGen
AXGN
|
26.2 M | $ 30.99 | -5.06 % | $ 1.43 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
53.8 M | $ 15.76 | -1.13 % | $ 370 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
44.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
1.73 M | - | 1.37 % | $ 20.5 M | USA |
 |
LENSAR
LNSR
|
6.38 M | $ 5.63 | -4.41 % | $ 67.3 M | USA |
 |
Medtronic PLC
MDT
|
6.52 B | $ 86.42 | 0.15 % | $ 111 B | USA |
 |
Myomo
MYO
|
4.1 M | $ 0.68 | -2.9 % | $ 28.5 M | USA |
 |
Butterfly Network
BFLY
|
20.8 M | $ 4.05 | -1.94 % | $ 857 M | USA |
 |
Nevro Corp.
NVRO
|
71.9 M | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
7.55 M | $ 0.61 | 3.37 % | $ 38 M | USA |
 |
BIOLASE
BIOL
|
5.48 M | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
11.7 M | $ 9.67 | -0.31 % | $ 346 M | USA |
 |
BioSig Technologies
BSGM
|
109 K | - | 37.08 % | $ 85.7 M | USA |
 |
Alphatec Holdings
ATEC
|
97.3 M | $ 11.03 | 0.55 % | $ 1.66 B | USA |
 |
Insulet Corporation
PODD
|
161 M | $ 202.46 | -0.51 % | $ 14.2 B | USA |
 |
CONMED Corporation
CNMD
|
248 M | $ 34.54 | 1.35 % | $ 1.07 B | USA |